Connectomica is a drug discovery company that focuses on the control of the inflammatory response using the human connexin hemichannel as a target. The company has developed a new drug to treat muscular dystrophy with encouraging results.
Originary from: Chile
Founder: Tomás Pérez-Acle, Juan Carlos Sáez, Carlos Lagos
In Science & Business Park since: 2016
Phone: +56 2 2367 2023